Press Release: Datopotamab-Deruxtecan Demonstrates Survival Benefit in First-Line Metastatic Triple-Negative Breast Cancer
OncoDaily Party Berlin 2025
2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy
Amol Akhade: New Molecules to Look Forward to in GI Cancers at ESMO 2025
Yelak Biru: The Age of the Tech-Empowered Patient Partnership
100 Influential People in Oncology 2025 - Nominations are Open!
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025
Nicholas DeVito: The Importance and Urgency of Robust NIH and NCI Funding
